Clinical Trial

Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-24.
Status change: Not Yet Recruiting → Recruiting 2024-09-03
Trial Details
NCT Number NCT06479343
Lead Sponsor Ton-Bridge Medical Tech. Co., Ltd
Conditions Intracranial Arteriovenous Malformations
Enrollment 170 participants
Start Date 2024-06-27
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-19